Skip to search formSkip to main contentSkip to account menu

miriplatin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Transcatheter arterial therapies for hepatocellular carcinoma (HCC) have developed during the last decade. A fine powder… 
2017
2017
BackgroundThis prospective study investigated the superiority of transarterial chemoembolization (TACE) with miriplatin over TACE… 
Highly Cited
2016
Highly Cited
2016
To clarify the hemodynamic changes under balloon occlusion of the hepatic artery and to identify predictors of the short-term… 
2015
2015
Balloon‐occluded transcatheter arterial chemoembolization (B‐TACE) using a microballoon catheter was performed to administrate… 
2014
2014
Background Miriplatin (MPT) is a novel platinum complex used in TACE that shows promise for the treatment of hepatocellular… 
2012
2012
PurposeTo compare local control effects of superselective transcatheter arterial chemoembolization (TACE) using epirubicin (EPI… 
2012
2012
OBJECTIVE The purpose of this retrospective study was to compare the anti-tumor and adverse effects of transcatheter arterial… 
2011
2011
AIM To determine the safety and usefulness of a novel anticancer drug, miriplatin, in transarterial chemoembolization (TACE) for… 
2011
2011
Background SM-11355 is a platinum complex developed to treat hepatocellular carcinoma (HCC) via administration into the hepatic… 
2009
2009
Miriplatin is a lipophilic platinum complex which contains myristates as leaving groups and diaminocyclohexane as a carrier…